Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Osman, Kostek"'
Autor:
Seda Kahraman, Serdar Karakaya, Muhammed Ali Kaplan, Sema Sezgin Goksu, Akin Ozturk, Zehra Sucuoglu Isleyen, Jamshid Hamdard, Sedat Yildirim, Tolga Dogan, Selver Isik, Abdussamet Celebi, Burcu Belen Gulbagci, Nail Paksoy, Mutlu Dogan, Haci Mehmet Turk, Ahmet Bilici, Ali Murat Tatli, Sinem Akbas, Nedim Turan, Ilhan Hacibekiroglu, Gamze Gokoz Dogu, Adnan Aydiner, Ahmet Taner Sumbul, Serap Akyurek, Merih Yalciner, Ahmet Demirkazik, Pinar Gursoy, Musa Baris Aykan, Elif Sahin, İbrahim Karadag, Osman Kostek, Muhammed Muhiddin Er, Mehmet Artaç, Yakup Duzkopru, Dincer Aydin, Deniz Isik, Yusuf Karakas, Saadettin Kilickap, Cihan Erol, Bilgin Demir, Burak Civelek, Yakup Ergun, Muhammed Bulent Akinci, Izzet Dogan, Nuri Karadurmus, Perran Fulden Yumuk, Mehmet Ali Nahit Sendur
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Central nervous system (CNS) metastases can be seen at a rate of 30% in advanced stages for patients with non-small cell lung cancer (NSCLC). Growing evidence indicates the predictive roles of driver gene mutations in the development of brai
Externí odkaz:
https://doaj.org/article/dfd4fc84465f4b4985707fa241e217b7
Autor:
Rukiye Arikan, Salih Ozguven, Tugba Akin Telli, Selver Isik, Nazım Can Demircan, Tugba Basoglu, Alper Yasar, Abdussamet Celebi, Nuh Filizoglu, Hilal Sagiroglu Ustun, Ilker Tinay, Tunc Ones, Halil Turgut Turoglu, Tanju Yusuf Erdil, Mehmet Akif Ozturk, Ozlem Ercelep, Vedat Bayoglu, Osman Kostek, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
Acta Radiologica. 64:2040-2049
Background Prognostic markers in metastatic renal cell cancer (mRCC) are still insufficient. Any prognostic model objectively determines disease burden. Purpose To investigate the relationship between 18-fluorodeoxyglucose (18F-FDG) positron emission
Autor:
Tugba Akin Telli, Mehmet Akif Ozturk, Ozkan Alan, Rahib Hasanov, Osman Kostek, Rukiye Arikan, Tugba Basoglu, Serap Kaya, Ozlem Ercelep, Nalan Akgul Babacan, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
Future Oncology. 18:2425-2439
Breast cancer (BC) remains the most common cancer among women worldwide. Hormone receptor-positive (estrogen receptor- and/or progesterone receptor-positive) BC represents 70% of all cases. Advances in the treatment of disease lead to improved patien
Autor:
Nazım Can Demircan, Faysal Dane, Rukiye Arikan, Tanju Yusuf Erdil, Ozlem Ercelep, Perran Fulden Yumuk, Tugba Akin Telli, Osman Kostek, Handan Kaya, Hülya Şahin Özkan, Salih Ozguven, Mustafa Umit Ugurlu, Merve Çınar, Tunc Ones, Tugba Basoglu
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular. 41:171-178
Resumen Objetivo Investigamos la correlacion entre los indices de PET/TC con 18F-FDG y la respuesta patologica en el cancer de mama tratado con quimioterapia neoadyuvante (QNA), que se puntuo con el sistema de carga de cancer residual (RCB) despues d
Publikováno v:
Nefrología, Vol 36, Iss 6, Pp 653-659 (2016)
Objective: To evaluate renal impairment in type 2 diabetic patients with normoalbuminuria or microalbuminuria by detection of serum cystatin C and serum and urinary TGF-β levels. Methods: Cross-sectional study conducted at the Department of Endocrin
Externí odkaz:
https://doaj.org/article/33a4ebdd42154332a58e7ede0a6e6d54
Autor:
Bulent Erdogan, Erkan Ozcan, Ivo Gokmen, Ali Gokyer, Ahmet Kucukarda, Osman Kostek, MuhammetBekir Hacioglu, Sernaz Uzunoglu, Irfan Cicin
Aim: In this study, we aimed to analyze the effect of prognostic nutritional index and neutrophile lymphocyte ratio on the overall survival (OS) in patients treated with regorafenib. Materials and Methods: Metastatic colorectal cancer (CRC) patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a2233373efef4e578a6dd4efddf2505
https://hdl.handle.net/11424/290935
https://hdl.handle.net/11424/290935
Autor:
Osman Kostek, Ahmet Kucukarda, Erkan Ozcan, Irfan Cicin, Sernaz Uzunoglu, Ali Gökyer, Muhammet Bekir Hacioglu, Sezin Sayın, İvo Gökmen, Bulent Erdogan
Publikováno v:
Journal of Gastrointestinal Cancer. 53:31-40
Transverse colon cancer (TCC) is a rare condition that accounts for 10% of all colon cancers. TCC was accepted more likely right-sided colon cancers. We aimed to investigate whether TCC differs from other colon tumors by using clinical, pathological,
Autor:
Kadir Eser, Pinar Saip, Erdem Cubukcu, Fuat Demirelli, Ozkan Alan, Zuleyha Calikusu, Aykut Bahceci, Ali Alkan, Hacer Demir, Mahmut Büyükşimşek, Cemile Karadeniz, Erhan Gokmen, Naziye Ak, Mehmet Bilici, Altay Aliyev, Turkkan Evrensel, Oznur Bal, Atakan Demir, Özge Keskin, Nilgün Yildirim, Saadettin Kilickap, Semra Paydas, Atike Gökçen Demiray, Kezban Nur Pilanci, Ali Gökyer, Perran Fulden Yumuk, Birol Yildiz, Duygu Ilke Cikman, Ismail Beypinar, Taner Korkmaz, Sinan Yavuz, Burcu Çakar, Erkan Arpaci, Gulsah Seydaoglu, Ferhat Ferhatoglu, Ahmet Z. Sahin, Gulcan Bulut, Serkan Degirmencioglu, Cengiz Karacin, Mutlu Dogan, Havva Yesil Cinkir, Kerem Okutur, Semiha Urvay, Deniz Işik, Melih Simsek, Osman Kostek, Meltem Baykara, Salim Basol Tekin, Deniz Yamac
Publikováno v:
Cancer Investigation. 39:473-481
Aim: The aim of this study is to evaluate the efficacy and toxicity of trastuzumab emtansine (T-DM1) in cases with metastatic breast cancer (mBC) in different lines of treatment. Method: Retrospective analysis of T-DM1 results of human epidermal grow
Autor:
Erkan Ozcan, Ahmet Kucukarda, İvo Gökmen, Irfan Cicin, Sezin Sayın, Bulent Erdogan, Osman Kostek, Ebru Tastekin, Sernaz Uzunoglu, Bekir Hacioglu, Ali Gökyer
Publikováno v:
Tumori Journal. 108:141-146
Objective: To evaluate clinical and demographic characteristics and the results of cytotoxic treatments of KRASG12C, KRASother, and next-generation sequencing (NGS) panel negative patients. Methods: NGS data of 1264 patients with non-small cell lung
Autor:
Rukiye Arikan, Ozlem Ercelep, Perran Fulden Yumuk, Tugba Akin Telli, Handan Kaya, Osman Kostek, Nazım Can Demircan, Mustafa Umit Ugurlu, Tanju Yusuf Erdil, Faysal Dane, Merve Çınar, Tunc Ones, Tugba Basoglu, Hülya Şahin Özkan, Salih Ozguven
Aim: We investigated the correlation between 18F-FDG PET/CT indices and pathological response in breast cancer treated with neoadjuvant chemotherapy (NACT) which was scored with Residual Cancer Burden (RCB) system after surgery. Our aim is to detect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2771fdd183b2ddb57635b410ea1a2f0
https://hdl.handle.net/11424/289944
https://hdl.handle.net/11424/289944